TECX Insider Trading

Insider Ownership Percentage: 9.20%
Insider Buying (Last 12 Months): $18,767,941.54
Insider Selling (Last 12 Months): $0.00

Tectonic Therapeutic Insider Trading History Chart

This chart shows the insider buying and selling history at Tectonic Therapeutic by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$7.25Mbought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$10M-$5M$0$5M$10MTotal Insider BuyingTotal Insider Selling

Tectonic Therapeutic Share Price & Price History

Current Price: $23.51
Price Change: Price Decrease of -1.11 (-4.51%)
As of 03/13/2025 05:00 PM ET

This chart shows the closing price history over time for TECX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AprMayJunJulAugSepOctNovDecJanFebMar$23.51Closing price on 03/13/25:

Tectonic Therapeutic Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Tectonic Therapeutic (NASDAQ:TECX)

62.63% of Tectonic Therapeutic stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TECX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$30Mbought$13MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$20M$0$20MTotal InflowsTotal Outflows
Tectonic Therapeutic logo
Tectonic Therapeutic, Inc. engages in discovery and development of therapeutic proteins & antibodies. The company was founded by Timothy A. Springer and Andrew Kruse in 2019 and is headquartered in Watertown, MA.
Read More on Tectonic Therapeutic

Today's Range

Now: $23.51
Low: $23.31
High: $25.61

50 Day Range

MA: $35.53
Low: $21.31
High: $54.84

52 Week Range

Now: $23.51
Low: $13.80
High: $61.07

Volume

84,010 shs

Average Volume

375,152 shs

Market Capitalization

$346.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.71

Who are the company insiders with the largest holdings of Tectonic Therapeutic?

Tectonic Therapeutic's top insider investors include:
  1. Timothy A Springer (Director)
  2. Daniel Lochner (CFO)
Learn More about top insider investors at Tectonic Therapeutic.

Who are the major institutional investors of Tectonic Therapeutic?

Tectonic Therapeutic's top institutional investors include:
  1. Farallon Capital Management LLC — 4.83%
  2. 5AM Venture Management LLC — 4.05%
  3. Paradigm Biocapital Advisors LP — 3.29%
  4. Vanguard Group Inc. — 2.45%
  5. Balyasny Asset Management L.P. — 1.67%
  6. Susquehanna International Group LLP — 1.13%
Learn More about top institutional investors of Tectonic Therapeutic stock.

Which institutional investors are selling Tectonic Therapeutic stock?

In the previous quarter, TECX stock was sold by these institutional investors:
  1. Atlas Venture Life Science Advisors LLC
  2. Vanguard Group Inc.
  3. ADAR1 Capital Management LLC
  4. 5AM Venture Management LLC
  5. Boothbay Fund Management LLC
  6. Renaissance Technologies LLC
  7. Bridgeway Capital Management LLC
  8. Wells Fargo & Company MN

Which institutional investors are buying Tectonic Therapeutic stock?

During the last quarter, TECX stock was purchased by institutional investors including:
  1. Paradigm Biocapital Advisors LP
  2. Farallon Capital Management LLC
  3. Invesco Ltd.
  4. Susquehanna International Group LLP
  5. Balyasny Asset Management L.P.
  6. Woodline Partners LP
  7. Soleus Capital Management L.P.
  8. Jane Street Group LLC
During the previous year, these company insiders have bought Tectonic Therapeutic stock:
  1. Timothy A Springer (Director)
  2. Daniel Lochner (CFO)
Learn More investors buying Tectonic Therapeutic stock.